Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study

被引:21
|
作者
Yin, Shi-Wei [1 ]
Zhou, Zheng [1 ]
Wang, Jun-Ling [2 ]
Deng, Yun-Feng [2 ]
Jing, Hui [1 ]
Qiu, Yi [3 ]
机构
[1] Shandong Univ, Shandong Prov Publ Hlth Clin Ctr, Katharine Hsu Int Res Inst Infect Dis, Affiliated Hosp, Jinan 250013, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Publ Hlth Clin Ctr, Dept Clin Lab, Affiliated Hosp, Jinan 250013, Shandong, Peoples R China
[3] Maternal & Child Hlth Care Hosp Shandong Prov, Key Lab Birth Regulat & Control Technol, Natl Hlth Commiss China, 238 East Rd Jingshi, Jinan 250014, Shandong, Peoples R China
关键词
Asymptomatic; COVID-19; Interleukin; Lymphocyte subset; SARS-CoV-2; Viral load; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; PERIPHERAL-BLOOD;
D O I
10.1186/s12985-021-01597-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals. The aim of the present study is to investigate the laboratory characteristics of the viral load, lymphocyte subset and cytokines in asymptomatic individuals with SARS-CoV-2 infection in comparison with those in symptomatic patients with COVID-19. Methods From January 24, 2020, to April 11, 2020, 48 consecutive subjects were enrolled in this study. Viral loads were detected by RT-PCR from throat-swab, sputum and feces samples. Lymphocyte subset levels of CD3 + , CD4 + , and CD8 + T lymphocytes, B cells and NK cells were determined with biological microscope and flow cytometric analysis. Plasma cytokines (IL2, IL4, IL5, IL6, IL8, IL10, TNF-alpha, IFN-alpha and IFN-gamma) were detected using flow cytometer. Analysis of variance (ANOVA), Chi-square or Fisher's exact test and Pearson's Correlation assay was used for all data. Results Asymptomatic (AS), mild symptoms (MS) and severe or critical cases (SCS) with COVID-19 were 11 (11/48, 22.9%), 26 (54.2%, 26/48) and 11 cases (11/48, 22.9%), respectively. The mean age of AS group (47.3 years) was lower than SCS group (63.5 years) (P < 0.05). Diabetes mellitus in AS, MS and SCS patients with COVID-19 were 0, 6 and 5 cases, respectively, and there was a significant difference between AS and SCS (P < 0.05). No statistical differences were found in the viral loads of SARS-CoV-2 between AS, MS and SCS groups on admission to hospital and during hospitalization. The concentration of CD 3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), CD3 + CD8 + T cells (P < 0.01), and B cells (P < 0.05) in SCS patients was lower than in AS and MS patients, while the level of IL-5 (P < 0.05), IL-6 (P < 0.05), IL-8 (P < 0.01) and IL-10 (P < 0.01), and TNF-alpha (P < 0.05) was higher. The age was negatively correlated with CD3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), and positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05), and IL-10 (P < 0.05). The viral loads were positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05) and IL-10 (P < 0.05), while negatively correlated with CD 3 + T cells (P < 0.05) and CD3 + CD4 + T cells (P < 0.05). Conclusions The viral loads are similar between asymptomatic, mild and severe or critical patients with COVID-19. The severity of COVID-19 may be related to underlying diseases such as diabetes mellitus. Lymphocyte subset and plasma cytokine levels may be as the markers to distinguish severely degrees of disease, and asymptomatic patients may be as an important source of infection for the COVID-19.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
    Corman, Victor M.
    Rabenau, Holger F.
    Adams, Ortwin
    Oberle, Doris
    Funk, Markus B.
    Keller-Stanislawski, Brigitte
    Timm, Joerg
    Drosten, Christian
    Ciesek, Sandra
    [J]. TRANSFUSION, 2020, 60 (06) : 1119 - 1122
  • [32] Placental Evaluation in Symptomatic versus Asymptomatic Mothers with SARS-CoV-2 Infection
    Najafzadeh, Parisa
    Gomez, Nicole
    Wang, Tiannan
    Lee, Richard
    Walia, Saloni
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 724 - 725
  • [33] Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients
    Isao Yokota
    Takeshi Hattori
    Peter Y. Shane
    Satoshi Konno
    Atsushi Nagasaka
    Kimihiro Takeyabu
    Shinichi Fujisawa
    Mutsumi Nishida
    Takanori Teshima
    [J]. Scientific Reports, 11
  • [34] Placental Evaluation in Symptomatic versus Asymptomatic Mothers with SARS-CoV-2 Infection
    Najafzadeh, Parisa
    Gomez, Nicole
    Wang, Tiannan
    Lee, Richard
    Walia, Saloni
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 724 - 725
  • [35] Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients
    Yokota, Isao
    Hattori, Takeshi
    Shane, Peter Y.
    Konno, Satoshi
    Nagasaka, Atsushi
    Takeyabu, Kimihiro
    Fujisawa, Shinichi
    Nishida, Mutsumi
    Teshima, Takanori
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Asymptomatic peripheral neuropathy in patients with SARS-CoV-2 infection
    Schirinzi, Erika
    Gandoglia, Ilaria
    Assini, Andrea
    Rikani, Klaudio
    Siri, Giacomo
    Pontali, Emanuele
    Del Sette, Massimo
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [37] Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
    Sui, Zhiwei
    Dai, Xinhua
    Lu, Qingbin
    Zhang, Yulan
    Huang, Min
    Li, Shufen
    Peng, Tao
    Xie, Jie
    Zhang, Yongzhuo
    Wu, Chunchen
    Xia, Jianbo
    Dong, Lianhua
    Yang, Jiayi
    Huang, Wenfeng
    Liu, Siyuan
    Wang, Ziquan
    Li, Ke
    Yang, Qingfang
    Zhou, Xi
    Wu, Ying
    Liu, Wei
    Fang, Xiang
    Peng, Ke
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [38] Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
    Zhiwei Sui
    Xinhua Dai
    Qingbin Lu
    Yulan Zhang
    Min Huang
    Shufen Li
    Tao Peng
    Jie Xie
    Yongzhuo Zhang
    Chunchen Wu
    Jianbo Xia
    Lianhua Dong
    Jiayi Yang
    Wenfeng Huang
    Siyuan Liu
    Ziquan Wang
    Ke Li
    Qingfang Yang
    Xi Zhou
    Ying Wu
    Wei Liu
    Xiang Fang
    Ke Peng
    [J]. Signal Transduction and Targeted Therapy, 6
  • [39] Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
    Kim, Seong Eun
    Jeong, Hae Seong
    Yu, Yohan
    Shin, Sung Un
    Kim, Soosung
    Oh, Tae Hoon
    Kim, Uh Jin
    Kang, Seung-Ji
    Jang, Hee-Chang
    Jung, Sook-In
    Park, Kyung-Hwa
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95 : 441 - 443
  • [40] Asymptomatic cases with SARS-CoV-2 infection
    Wang, Yishan
    Kang, Hanyujie
    Liu, Xuefeng
    Tong, Zhaohui
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1401 - 1403